# Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

> **NCT01706224** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 757 (actual)

## Conditions studied

- Pertussis

## Interventions

- **PROCEDURE:** Blood sample
- **OTHER:** Data collection
- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT01706224
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2014-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706224, "Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01706224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*